Haemonetics Corporation: Clinical Trials

22 trials sponsored by Haemonetics Corporation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 recruiting, 2 unknown, 1 terminated. 5 Not applicable, 3 Phase 4, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 4, Recruiting 1
Phase 43Completed 2, Unknown 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow Haemonetics Corporation: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SAvvywire for Pacing and Procedural Hemodynamics In Transcatheter Aortic Valve Replacement Evaluation
TAVI(Transcatheter Aortic Valve Implantation), Aortic Valve Disease
Recruitingdr Pim A.L. Tonino3002026-01-122026-03-11
VASC-AF Study: Vascular Closure vs Manual Compression
Vacular closure - Atrial Fibrillation
Not applicableRecruitingAsklepios proresearch1002025-04-222026-02-17
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
TEG indices - Liver Cancer, Esophageal Cancer
RecruitingUniversity of Colorado, Denver2002022-06-262026-08-24
An Observational Trial to Assess the Performance of the TEG® 6s Diagnostic System With the Citrated K, KH, RTH, FFH Cartridge
TEG 6s Citrated K, KH, RTH, FFH Cartridge, Clauss Fibrinogen - Surgery
CompletedHaemonetics Corporation3382021-12-092024-04-08
Normal Reference Range Study With the TEG6s Heparin Neutralization Cartridge in Healthy Volunteers
TEG 6s Citrated K, KH, RTH, and FFH Cartridge, Clauss Fibrinogen - Healthy
CompletedHaemonetics Corporation1812021-07-282024-02-15
The Evaluation of Hemostasis in Hospitalized COVID-19 Patients
Phlebotomy - COVID-19
UnknownLifeBridge Health1002020-06-302020-10-22
IMPACT (Improving Plasma Collection) Clinical Trial
Updated Plasma Collection Feature, Current Plasma Collection Approach - Apheresis Related Hypotension
Not applicableCompletedHaemonetics Corporation34432020-01-062021-04-09
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
TEG6s DOAC Cartridge - DOAC Eligible Subjects
CompletedHaemonetics Corporation3852016-08-012020-02-11
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
POLFA (Needle Assembly), Kawasumi (Needle Assembly) - Transmission, Blood, Recipient/Donor
Not applicableCompletedHaemonetics Corporation622015-06-012022-04-29
Procedure For The Reference Range Study For Absolute MA
Transmission, Blood, Recipient/Donor
CompletedHaemonetics Corporation1612014-05-012015-04-03
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
SOLX (Investigational), AS-3 (Control) - Blood Donors
Phase 1CompletedHaemonetics Corporation1702014-04-012022-04-25
Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)
Red Blood Cell Donation
CompletedHaemonetics Corporation602013-01-012013-10-11
Clinical Evaluation of the OrthoPAT Advance System
OrthoPat Advance - Transmission, Blood, Recipient/Donor
CompletedHaemonetics Corporation842012-12-012013-11-20
Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients
Clopidogrel 75mg, Clopidogrel 150mg, Aspirin 100mg - Coronary Heart Disease
Not applicableCompletedChinese Academy of Medical Sciences, Fuwai Hospital10782012-09-012017-07-19
Pilot Study Evaluating Alterations in Thrombogenicity and Platelet Reactivity Following Lower Extremity Arthroplasty
Arixtra, Pneumatic compression stockings, Aspirin - Primary Total Hip and Knee Arthroplasty
Phase 4CompletedLifeBridge Health542012-04-012014-04-21
RapidTEG MA Validation
Coagulation, Platelet Function
TerminatedHaemonetics Corporation172011-07-012013-09-16
Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial
Fibrinogen Concentrate, Isotonic Saline - Postpartum Haemorrhage
Phase 2 / Phase 3CompletedCopenhagen University Hospital at Herlev2492011-05-012013-09-20
Thromboelastography (TEG) Reference Range Study
Coagulation
CompletedHaemonetics Corporation1592011-04-012012-09-05
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
RapidTEG test - Coagulopathy
CompletedThe University of Texas Health Science Center, Houston14502010-11-012012-12-18
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
Blood product transfusion based on conventional coagulation tests., Blood product transfusion based on rapid thrombelastography (r-TEG) results. - Acute Coagulopathy
Not applicableCompletedDenver Health and Hospital Authority1142010-09-012019-01-08

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Hemostatic Disorders (2)  ·  Thrombosis (2)  ·  Wounds and Injuries (2)  ·  Adenocarcinoma of Lung (1)  ·  Aortic Valve Disease (1)  ·  Atrial Fibrillation (1)  ·  Biliary Tract Neoplasms (1)  ·  COVID-19 (1)  ·  Colorectal Neoplasms (1)  ·  Coronary Disease (1)  ·  Esophageal Neoplasms (1)  ·  Hemorrhage (1)  ·  Liver Neoplasms (1)  ·  Osteoarthritis (1)  ·  Pancreatic Neoplasms (1)

Interventions

Aspirin (2)  ·  Clopidogrel (2)  ·  Thrombelastography (2)  ·  Cilostazol (1)  ·  Drainage (1)  ·  Epoetin Alfa (1)  ·  Erythropoietin (1)  ·  Esomeprazole (1)  ·  Fibrinogen (1)  ·  Fondaparinux (1)  ·  Intermittent Pneumatic Compression Devices (1)  ·  Pantoprazole (1)  ·  Phlebotomy (1)  ·  Proton Pump Inhibitors (1)  ·  Rabeprazole (1)

Countries

United States (16)  ·  Netherlands (2)  ·  China (1)  ·  Denmark (1)  ·  Germany (1)  ·  Taiwan (1)

Top investigators

Jose Cancelas, MD (2)  ·  Ana Gleisner, MD (1)  ·  Anne J. Wikkelsoe, MD (1)  ·  Arash Afshari, MD (1)  ·  Bryan Cotton, MD (1)  ·  Ernest E. Moore, M.D. (1)  ·  Ernest E. Moore, MD (1)  ·  Fu-Tien Chiang, MD, Phd (1)  ·  Hellen McKinnon Edwards, M.D. (1)  ·  Jakob Stensballe, MD, PhD (1)  ·  Jan Hartmann, MD (1)  ·  Jens Langhoff-Roos, MD, DmSc (1)  ·  Jerome Gottschall, MD (1)  ·  Jonathan Waters, MD (1)

Results publications

PMID 22805300, PMID 25586727, PMID 29420189, PMID 33760230, PMID 34369413, PMID 40965969

NIH funding

2009 (1)